GYNECOLOGIC CANCERS
Clinical trials for GYNECOLOGIC CANCERS explained in plain language.
Never miss a new study
Get alerted when new GYNECOLOGIC CANCERS trials appear
Sign up with your email to follow new studies for GYNECOLOGIC CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets rare cancer mutation in early trial
Disease control OngoingThis early-phase study tests a new oral drug, ATV-1601, in people with advanced solid tumors or certain breast cancers that have a specific AKT1 E17K mutation. The main goals are to check safety, find the right dose, and see how the drug moves through the body. About 134 adults w…
Matched conditions: GYNECOLOGIC CANCERS
Phase: PHASE1 • Sponsor: Atavistik Bio, Inc • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Rare surgery for recurrent cancer: how does it affect quality of life?
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 21 patients who had a very extensive surgery called pelvic exenteration for recurrent gynecologic cancer. The goal is to understand how the surgery affects their quality of life and sexuality using standard questionnaires. The results will help doctors better p…
Matched conditions: GYNECOLOGIC CANCERS
Sponsor: Tampere University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC